- Home
- SPPP vs OCGN Comparison
SPPP vs OCGN Comparison
Compare SPPP & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPP
- OCGN
- Stock Information
- Founded
- SPPP 2011
- OCGN 2013
- Country
- SPPP Canada
- OCGN United States
- Employees
- SPPP N/A
- OCGN N/A
- Industry
- SPPP
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPPP
- OCGN Health Care
- Exchange
- SPPP NYSE
- OCGN Nasdaq
- Market Cap
- SPPP 172.2M
- OCGN 189.6M
- IPO Year
- SPPP N/A
- OCGN N/A
- Fundamental
- Price
- SPPP $9.74
- OCGN $0.67
- Analyst Decision
- SPPP
- OCGN Strong Buy
- Analyst Count
- SPPP 0
- OCGN 3
- Target Price
- SPPP N/A
- OCGN $6.33
- AVG Volume (30 Days)
- SPPP 183.3K
- OCGN 3.2M
- Earning Date
- SPPP 01-01-0001
- OCGN 05-09-2025
- Dividend Yield
- SPPP N/A
- OCGN N/A
- EPS Growth
- SPPP N/A
- OCGN N/A
- EPS
- SPPP N/A
- OCGN N/A
- Revenue
- SPPP N/A
- OCGN $4,522,000.00
- Revenue This Year
- SPPP N/A
- OCGN N/A
- Revenue Next Year
- SPPP N/A
- OCGN N/A
- P/E Ratio
- SPPP N/A
- OCGN N/A
- Revenue Growth
- SPPP N/A
- OCGN N/A
- 52 Week Low
- SPPP $8.55
- OCGN $0.52
- 52 Week High
- SPPP $11.39
- OCGN $2.06
- Technical
- Relative Strength Index (RSI)
- SPPP 59.69
- OCGN 46.49
- Support Level
- SPPP $9.50
- OCGN $0.65
- Resistance Level
- SPPP $9.51
- OCGN $0.75
- Average True Range (ATR)
- SPPP 0.10
- OCGN 0.05
- MACD
- SPPP 0.03
- OCGN -0.01
- Stochastic Oscillator
- SPPP 96.67
- OCGN 15.38
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").